A Study of ART0380 for the Treatment of Advanced or Metastatic Solid Tumors

NCT04657068 · clinicaltrials.gov ↗

PHASE1,PHASE2

Phase

RECRUITING

Status

442

Enrollment

INDUSTRY

Sponsor class

Conditions

Advanced Cancer
Metastatic Cancer
Ovarian Cancer
Primary Peritoneal Cancer
Fallopian Tube Cancer
Endometrial Cancer
Metastatic Colorectal Cancer
Pancreatic Ductal Adenocarcinoma
Acinar Cell Carcinoma

Interventions

DRUG: ART0380
DRUG: Gemcitabine
DRUG: Irinotecan

Sponsor

Artios Pharma Ltd